The Type III Transforming Growth Factor-β Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer
- 1 February 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (3), 1090-1098
- https://doi.org/10.1158/0008-5472.can-06-3117
Abstract
The transforming growth factor-β (TGF-β) signaling pathway has an important role in regulating normal prostate epithelium, inhibiting proliferation, differentiation, and both androgen deprivation–induced and androgen-independent apoptosis. During prostate cancer formation, most prostate cancer cells become resistant to these homeostatic effects of TGF-β. Although the loss of expression of either the type I (TβRI) or type II (TβRII) TGF-β receptor has been documented in ∼30% of prostate cancers, most prostate cancers become TGF-β resistant without mutation or deletion of TβRI, TβRII, or Smads2, 3, and 4, and thus, the mechanism of resistance remains to be defined. Here, we show that type III TGF-β receptor (TβRIII or betaglycan) expression is decreased or lost in the majority of human prostate cancers as compared with benign prostate tissue at both the mRNA and protein level. Loss of TβRIII expression correlates with advancing tumor stage and a higher probability of prostate-specific antigen (PSA) recurrence, suggesting a role in prostate cancer progression. The loss of TβRIII expression is mediated by the loss of heterozygosity at the TGFBR3 genomic locus and epigenetic regulation of the TβRIII promoter. Functionally, restoring TβRIII expression in prostate cancer cells potently decreases cell motility and cell invasion through Matrigel in vitro and prostate tumorigenicity in vivo. Taken together, these studies define the loss of TβRIII expression as a common event in human prostate cancer and suggest that this loss is important for prostate cancer progression through effects on cell motility, invasiveness, and tumorigenicity. [Cancer Res 2007;67(3):1090–8]Other Versions
This publication has 32 references indexed in Scilit:
- Non-Smad TGF-β signalsJournal of Cell Science, 2005
- Functions and regulation of transforming growth factor-beta (TGF-β) in the prostateEuropean Journal of Cancer, 2005
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- A Novel Mechanism for Regulating Transforming Growth Factor β (TGF-β) SignalingPublished by Elsevier BV ,2001
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Functional Roles for the Cytoplasmic Domain of the Type III Transforming Growth Factor β Receptor in Regulating Transforming Growth Factor β SignalingPublished by Elsevier BV ,2001
- Role of Transforming Growth Factor β in Human DiseaseThe New England Journal of Medicine, 2000
- Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sitesThe Journal of cell biology, 1994
- Expression cloning and characterization of the TGF-β type III receptorCell, 1991